Eris Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)
Eris Lifesciences Ltd · Outcome · 26 Oct 2026, 7:19 pm
Eris Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 892 (+12.6% YoY | +2.2% QoQ) ■ EBITDA: 309 (+7.3% YoY | +4.4% QoQ) ■ EBITDA Margin (%): 34.7 (-171 bps YoY | +74 bps QoQ) ■ PAT: 184 (+52.9% YoY | +29.1% QoQ) ■ EPS (INR): 13.3 (+50.4% YoY | +29.1% QoQ)
Original exchange filing (PDF)
More announcements from Eris Lifesciences Ltd
- as attached · 13 Nov 2026
- The Company will host "Eris Investor Meet - 2026" on November 19, 2026 · 29 Oct 2026
- as attached · 29 Oct 2026
- as attached · 27 Oct 2026
- as attached · 26 Oct 2026
- as attached · 26 Oct 2026
- as attached · 26 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 26 Oct 2026
